AI Article Synopsis
- Dihydroartemisinin (DHA), a derivative of artemisinin, effectively inhibits the growth and spread of glioma cells by inducing cell death (apoptosis).
- The study utilized various assays to demonstrate that DHA triggers apoptosis through the Protein Kinase B (AKT) pathway and decreases the expression of miR-21, which is linked to cell survival.
- Additionally, DHA promotes the expression of the protein RECK, which inhibits glioma cell invasion, highlighting its potential as a treatment for glioma.
Article Abstract
Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, is known to play important roles in inhibiting proliferation rate, inducing apoptosis, as well as hindering the metastasis and invasion of glioma cells, but the underlying mechanisms are still unclear so far. In this study, methyl thiazolyl tetrazolium (MTT), colony-forming, wound healing, invasion, and apoptosis assays were performed to investigate the effect of DHA on malignant glioma cells. Results showed that DHA induced apoptosis of malignant glioma cells through Protein Kinase B (AKT) axis, induced death of malignant glioma cells by downregulating miR-21, and inhibited the invasion of malignant glioma cells corresponding with up-regulation of the reversion-inducing-cysteine-rich protein with kazal motifs (RECK). These results revealed that AKT axis, miR-21, and RECK play pivotal roles in DHA killing malignant glioma cells, suggesting that DHA is a potential agent for treating glioma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343885 | PMC |
| http://dx.doi.org/10.3390/ijms18020350 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!